Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jacob B Johnson"'
Autor:
Michael F Harrison, Paul J Anderson, Jacob B Johnson, Maile Richert, Andrew D Miller, Bruce D Johnson
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148206 (2016)
INTRODUCTION:Acetazolamide, a carbonic anhydrase inhibitor, remains the only FDA approved pharmaceutical prophylaxis for acute mountain sickness (AMS) though its effectiveness after rapid transport in real world conditions is less clear. METHODS:Over
Externí odkaz:
https://doaj.org/article/81a71ab55452475e85e445ff0ca50ca9
Publikováno v:
Insects, Vol 9, Iss 4, p 132 (2018)
Mosquito-borne diseases account for the deaths of approximately 700,000 people annually throughout the world, with many more succumbing to the debilitating side effects associated with these etiologic disease agents. This is exacerbated in many count
Externí odkaz:
https://doaj.org/article/51956ab7a43e4b2688ead654492d948c
Autor:
Glenn M. Stewart, Andrew D. Miller, Girish Pathangey, Jacob B Johnson, Courtney M. Wheatley-Guy, Paul A. Anderson, Maile L Ceridon Richert, Bruce D. Johnson
Publikováno v:
International journal of sports medicine. 40(7)
This study aimed to evaluate the influence of physical activity on incidence of acute mountain sickness (AMS) by continuous activity monitoring in a free-living sample of South Pole workers over the initial 72 h at altitude exposure of 2,840 m (9,318
Publikováno v:
BMJ Open
Objective The modified early warning score (MEWS) is a ‘track and trigger’ score using routine physiological vital signs. The objective is to determine if the pretransfer MEWS can be used for predicting outcomes in trauma patients requiring inter
Autor:
Andrew D. Miller, Michael F. Harrison, Paul A. Anderson, Maile L Ceridon Richert, Bruce D. Johnson, Jacob B Johnson
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 2, p e0148206 (2016)
PLoS ONE, Vol 11, Iss 2, p e0148206 (2016)
INTRODUCTION:Acetazolamide, a carbonic anhydrase inhibitor, remains the only FDA approved pharmaceutical prophylaxis for acute mountain sickness (AMS) though its effectiveness after rapid transport in real world conditions is less clear. METHODS:Over
Publikováno v:
Chest. 130:164-171
Background The purpose of this study was to determine the influence of changes in cardiac size on total lung volume in patients with chronic heart failure compared to control subjects. Methods Forty-four patients and age-, gender-, and height-matched
Autor:
Maile L Ceridon Richert, Nicole M Herman, Jacob B Johnson, Bruce D. Johnson, Andrew D. Miller, Kathy A. O'Malley, Paul J. Anderson, Diane E. Grill
Publikováno v:
Advances in Genomics and Genetics.
Nicole M Herman,1 Diane E Grill,2 Paul J Anderson,1 Andrew D Miller,1 Jacob B Johnson,1 Kathy A O’Malley,1 Maile L Ceridon Richert,1 Bruce D Johnson1 1Department of Cardiovascular Diseases, 2Department of Biostatistics, Mayo Clinic Rochester, MN, U
Autor:
Maille Richert, Andrew D. Miller, Jacob B Johnson, Kathy A. O'Malley, Michael F. Harrison, Paul A. Anderson, Bruce D. Johnson
Publikováno v:
Aviation, space, and environmental medicine. 84(11)
INTRODUCTION: Progesterone has a number of properties that could influence the development of acute mountain sickness (AMS) including anti-inflammation respiratory smooth muscle relaxation ventilatory stimulation and antidiuretic characteristics. Ora
Physiological variables associated with the development of acute mountain sickness at the South Pole
Autor:
Andrew D. Miller, Kathy A. O'Malley, Jacob B Johnson, Michael F. Harrison, Paul A. Anderson, Maile L Ceridon Richert, Bruce D. Johnson
Publikováno v:
BMJ Open
Exposure to altitudes >2500 m can result in acute mountain sickness (AMS), a mild and usually self-limiting condition. Research has attempted to identify factors associated with developing AMS without controlling important factors related to the asce
Publikováno v:
The FASEB Journal. 27